{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:00:52Z","timestamp":1785474052729,"version":"3.56.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,30]]},"DOI":"10.7759\/cureus.113695","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:47:21Z","timestamp":1785473241000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive Value of the Soluble fms-Like Tyrosine Kinase-1\/Placental Growth Factor Ratio in Preeclampsia and Placenta Accreta Spectrum: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Ashima","family":"Taneja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guntas","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukriti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2020.03.043","article-title":"Prevalence of preeclampsia and eclampsia in adolescent pregnancy: a systematic review and meta-analysis of 291,247 adolescents worldwide since 1969","volume":"248","author":"Macedo TC","year":"2020","unstructured":"Macedo TC, Montagna E, Trevisan CM, et al.. Prevalence of preeclampsia and eclampsia in adolescent pregnancy: a systematic review and meta-analysis of 291,247 adolescents worldwide since 1969. Eur J Obstet Gynecol Reprod Biol. 2020, 248:177-86. 10.1016\/j.ejogrb.2020.03.043","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-019-0120-1","article-title":"Prevalence and associated factors of pre-eclampsia among pregnant women attending anti-natal care at Mettu Karl referal hospital, Ethiopia: cross-sectional study","volume":"25","author":"Belay AS","year":"2019","unstructured":"Belay AS, Wudad T. Prevalence and associated factors of pre-eclampsia among pregnant women attending anti-natal care at Mettu Karl referal hospital, Ethiopia: cross-sectional study. Clin Hypertens. 2019, 25:14. 10.1186\/s40885-019-0120-1","journal-title":"Clin Hypertens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233323","article-title":"Clinical presentation and outcomes of pre-eclampsia and eclampsia at a national hospital, Kenya: a retrospective cohort study","volume":"15","author":"Ndwiga C","year":"2020","unstructured":"Ndwiga C, Odwe G, Pooja S, Ogutu O, Osoti A, E Warren C. Clinical presentation and outcomes of pre-eclampsia and eclampsia at a national hospital, Kenya: a retrospective cohort study. PLoS One. 2020, 15:e0233323. 10.1371\/journal.pone.0233323","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee LA","year":"2022","unstructured":"Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia. N Engl J Med. 2022, 386:1817-32. 10.1056\/NEJMra2109523","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.20345","article-title":"Placenta accreta spectrum-a catastrophic situation in obstetrics","volume":"64","author":"Pegu B","year":"2021","unstructured":"Pegu B, Thiagaraju C, Nayak D, Subbaiah M. Placenta accreta spectrum-a catastrophic situation in obstetrics. Obstet Gynecol Sci. 2021, 64:239-47. 10.5468\/ogs.20345","journal-title":"Obstet Gynecol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101329","article-title":"First-trimester screening for placenta accreta spectrum","volume":"6","author":"Dar P","year":"2024","unstructured":"Dar P, Doulaveris G. First-trimester screening for placenta accreta spectrum. Am J Obstet Gynecol MFM. 2024, 6:101329. 10.1016\/j.ajogmf.2024.101329","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14952","article-title":"Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP)","volume":"47","author":"Collins SL","year":"2016","unstructured":"Collins SL, Ashcroft A, Braun T, et al.. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016, 47:271-5. 10.1002\/uog.14952","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.09.013","article-title":"Placenta accreta","volume":"203","author":"Belfort MA","year":"2010","unstructured":"Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010, 203:430-9. 10.1016\/j.ajog.2010.09.013","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.04.010","article-title":"Predictive value of sFlt-1, PlGF, sFlt-1\/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37\u202fweeks of pregnancy","volume":"12","author":"Birdir C","year":"2018","unstructured":"Birdir C, Droste L, Fox L, et al.. Predictive value of sFlt-1, PlGF, sFlt-1\/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37\u202fweeks of pregnancy. Pregnancy Hypertens. 2018, 12:124-8. 10.1016\/j.preghy.2018.04.010","journal-title":"Pregnancy Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189675","article-title":"The impact of hypoxia in early pregnancy on placental cells","volume":"22","author":"Zhao H","year":"2021","unstructured":"Zhao H, Wong RJ, Stevenson DK. The impact of hypoxia in early pregnancy on placental cells. Int J Mol Sci. 2021, 22:10.3390\/ijms22189675","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2020.11.004","article-title":"Review of MRI imaging for placenta accreta spectrum: pathophysiologic insights, imaging signs, and recent developments","volume":"104","author":"Kapoor H","year":"2021","unstructured":"Kapoor H, Hanaoka M, Dawkins A, Khurana A. Review of MRI imaging for placenta accreta spectrum: pathophysiologic insights, imaging signs, and recent developments. Placenta. 2021, 104:31-9. 10.1016\/j.placenta.2020.11.004","journal-title":"Placenta"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/NMC.0000000000000523","article-title":"Gestational hypertension and preeclampsia","volume":"44","author":"Wisner K","year":"2019","unstructured":"Wisner K. Gestational hypertension and preeclampsia. MCN Am J Matern Child Nurs. 2019, 44:170. 10.1097\/NMC.0000000000000523","journal-title":"MCN Am J Matern Child Nurs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.22541\/au.175267084.48078768\/v1","article-title":"Predictive value of the sFlt-1\/PlGF ratio in pre-eclampsia and placenta accreta spectrum: a prospective observational study [PREPRINT]","author":"Taneja A","year":"2025","unstructured":"Taneja A, Kaur G, Bansal E, Handa S, Gupta S. Predictive value of the sFlt-1\/PlGF ratio in pre-eclampsia and placenta accreta spectrum: a prospective observational study [PREPRINT]. Authorea Preprints. 2025, 10.22541\/au.175267084.48078768\/v1","journal-title":"Authorea Preprints"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1292458","article-title":"Development and validation of nomograms to predict clinical outcomes of preeclampsia","volume":"15","author":"Xia Y","year":"2024","unstructured":"Xia Y, Wang Y, Yuan S, et al.. Development and validation of nomograms to predict clinical outcomes of preeclampsia. Front Endocrinol (Lausanne). 2024, 15:1292458. 10.3389\/fendo.2024.1292458","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2017-0281","article-title":"Outcomes in oligohydramnios: the role of etiology in predicting pulmonary morbidity\/mortality","volume":"46","author":"Hesson A","year":"2018","unstructured":"Hesson A, Langen E. Outcomes in oligohydramnios: the role of etiology in predicting pulmonary morbidity\/mortality. J Perinat Med. 2018, 46:948-50. 10.1515\/jpm-2017-0281","journal-title":"J Perinat Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/uog.70075","article-title":"sFlt-1\/PlGF ratio thresholds for diagnosing pre-eclampsia in pregnant women with high blood pressure","volume":"66","author":"Pan X","year":"2025","unstructured":"Pan X, Peng J, Chen Y, Di X, Li P, Zhang G, Liu H. sFlt-1\/PlGF ratio thresholds for diagnosing pre-eclampsia in pregnant women with high blood pressure. Ultrasound Obstet Gynecol. 2025, 66:631-40. 10.1002\/uog.70075","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2024.10.002","article-title":"Antenatal maternal serum biomarkers as a predictor for placenta accreta spectrum disorders","volume":"158","author":"Wihakarat A","year":"2024","unstructured":"Wihakarat A, Singkhamanan K, Pranpanus S. Antenatal maternal serum biomarkers as a predictor for placenta accreta spectrum disorders. Placenta. 2024, 158:62-8. 10.1016\/j.placenta.2024.10.002","journal-title":"Placenta"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2020.1756313","article-title":"Values of serum sFlt-1, PLGF levels, and sFlt-1\/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients","volume":"42","author":"Zhu X","year":"2020","unstructured":"Zhu X, Chen L, Li R. Values of serum sFlt-1, PLGF levels, and sFlt-1\/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients. Clin Exp Hypertens. 2020, 42:601-7. 10.1080\/10641963.2020.1756313","journal-title":"Clin Exp Hypertens"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren S","year":"2022","unstructured":"Verlohren S, Brennecke SP, Galindo A, et al.. Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2022, 27:42-50. 10.1016\/j.preghy.2021.12.003","journal-title":"Pregnancy Hypertens"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501497-predictive-value-of-the-soluble-fms-like-tyrosine-kinase-1placental-growth-factor-ratio-in-preeclampsia-and-placenta-accreta-spectrum-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:47:35Z","timestamp":1785473255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501497-predictive-value-of-the-soluble-fms-like-tyrosine-kinase-1placental-growth-factor-ratio-in-preeclampsia-and-placenta-accreta-spectrum-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.113695","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}